These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12761093)

  • 21. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
    Fan X; Gao Q; Fu R
    Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y; Bao L; Yang X
    Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice.
    Biet F; Kremer L; Wolowczuk I; Delacre M; Locht C
    Infect Immun; 2002 Dec; 70(12):6549-57. PubMed ID: 12438324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
    Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
    J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.
    Juárez-Rodríguez MD; Arteaga-Cortés LT; Kader R; Curtiss R; Clark-Curtiss JE
    Infect Immun; 2012 Feb; 80(2):798-814. PubMed ID: 22144486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterologous Boosting With
    Liu SJ; Tian SC; Zhang YW; Tang T; Zeng JM; Fan XY; Wang C
    Front Immunol; 2020; 11():2036. PubMed ID: 32983151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY
    Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J; Xu W; Chen X; Zhao D; Wang Y
    Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved tuberculosis DNA vaccines by formulation in cationic lipids.
    D'Souza S; Rosseels V; Denis O; Tanghe A; De Smet N; Jurion F; Palfliet K; Castiglioni N; Vanonckelen A; Wheeler C; Huygen K
    Infect Immun; 2002 Jul; 70(7):3681-8. PubMed ID: 12065510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis.
    Lefèvre P; Denis O; De Wit L; Tanghe A; Vandenbussche P; Content J; Huygen K
    Infect Immun; 2000 Mar; 68(3):1040-7. PubMed ID: 10678905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterial ESAT-6 protein enhances mouse IFN-gamma responses to Mycoplasma hyopneumoniae P71 protein.
    Menon SA; Wannemuehler MJ; Mahairas GG; Minion FC
    J Interferon Cytokine Res; 2002 Jul; 22(7):807-13. PubMed ID: 12184919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.
    Qie YQ; Wang JL; Zhu BD; Xu Y; Wang QZ; Chen JZ; Wang HH
    Scand J Immunol; 2008 Feb; 67(2):133-9. PubMed ID: 18201368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.
    Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
    Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
    Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guérin.
    Rao V; Dhar N; Tyagi AK
    Scand J Immunol; 2003 Oct; 58(4):449-61. PubMed ID: 14507310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on immunogenicity elicited by a recombinant vaccine of rBCG-Rv3133c to fight against dormancy Mycobacterium tuberculosis].
    Deng Y; He H; Zhang B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):817-21. PubMed ID: 24059063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunobiological properties of a 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra.
    Sinha RK; Verma I; Khuller GK
    Vaccine; 1997; 15(6-7):689-99. PubMed ID: 9178471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and protective efficacy of heterologous prime-boost regimens with mycobacterial vaccines and recombinant adenovirus- and poxvirus-vectored vaccines against murine tuberculosis.
    You Q; Wu Y; Wu Y; Wei W; Wang C; Jiang D; Yu X; Zhang X; Wang Y; Tang Z; Jiang C; Kong W
    Int J Infect Dis; 2012 Nov; 16(11):e816-25. PubMed ID: 22921259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.